Xu JianMin

20PUBLICATIONS
51CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 24, 2026
Reply to: "Is Dual-Checkpoint Blockade Beneficial Beyond Prolonging Chemoradiotherapy-to-Surgery Interval in Rectal Cancer?" and "Dual Immunotherapy in the Neoadjuvant Interval for Locally Advanced Rectal Cancer: A New Hope?"

|May 04, 2026
Efficacy of Renin-Angiotensin System Inhibitors in Long-Term Oncologic Outcomes of Patients With Stage II/III Colon Cancer and Hypertension: A Target Trial Emulation.

|Feb 26, 2026
Consensus guidance of immune checkpoint inhibitors in locally advanced rectal cancer.

Zhengyang Yang, Fan Xia, Jian Li

|Jan 13, 2026
Randomized Parallel-Group Phase II Study (NEOTERIC) of Atezolizumab With or Without Tiragolumab After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.

Wentao Tang, Aiwen Wu, Ping Lan

|Nov 24, 2025
Chemotherapy alone versus chemotherapy plus targeted therapy as adjuvant therapy for initially unresectable colorectal cancer liver metastases: a multicenter cohort study.

Wenju Chang, Shizhao Zhou, Xu Guan

|Dec 31, 2024
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update.

Feng Wang, Gong Chen, Zhen Zhang

Pageof 4

Frequent Collaborators

3 joint publications

Qingyang Feng

2 joint publications

Dexiang Zhu

2 joint publications

Fei Liang

2 joint publications

Kefeng Ding